CEFEPIME HYDROCHLORIDE (CEFEPIME HYDROCHLORIDE) — FDA Approval ANDA212721 (ASTRAL)
CEFEPIME HYDROCHLORIDE (CEFEPIME HYDROCHLORIDE) — FDA Approval ANDA212721 (ASTRAL) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: CEFEPIME HYDROCHLORIDE; Active ingredients: CEFEPIME HYDROCHLORIDE; Application number: ANDA212721.
| Brand name | CEFEPIME HYDROCHLORIDE |
|---|---|
| Active ingredients | CEFEPIME HYDROCHLORIDE |
| Application number | ANDA212721 |
| Sponsor | ASTRAL |
| Dosage form | INJECTABLE |
| Route | INJECTION |
| Marketing status | Discontinued |
| Products in application | 2 |
| First approval date | 20200721 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →